Direct Meds GLP-1 vs MEDVi: Which GLP-1 Provider Is Better?
A side-by-side comparison of Direct Meds GLP-1 and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Direct Meds GLP-1
#18 of 317.9/10
Straightforward compounded GLP-1 program with transparent all-inclusive pricing and no hidden fees.
Visit Direct Meds GLP-1Higher Rated
MEDVi
#9 of 318.3/10
Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Direct Meds GLP-1 | MEDVi |
|---|---|---|
| Our Score | 7.9/10 | 8.3/10 |
| Starting Price | $280/mo | $179/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users wanting simple, all-inclusive pricing without insurance | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #18 | #9 |
Pros & Cons Compared
Direct Meds GLP-1
Pros
- +True all-inclusive pricing — $280/mo covers medication, consultations, shipping, and pharmacy fees with no add-ons
- +Clear dose-based pricing published on their site — no surprise cost increases when titrating up
- +Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval
- +Responsive customer support with live chat available during business hours
Cons
- −Compounded medications only — cannot prescribe brand-name Wegovy, Zepbound, or Ozempic
- −At $280/mo for compounded-only, it's pricier than competitors like Henry Meds ($199) or TrimRx ($179)
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Direct Meds GLP-1 with a score of 8.3/10 vs 7.9/10. If budget is your priority, MEDVi starts at $179/mo compared to Direct Meds GLP-1's $280/mo. Choose Direct Meds GLP-1 if you want: users wanting simple, all-inclusive pricing without insurance. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.